Neuroleptic malignant syndrome.
Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening complication of neuroleptic therapy. Its occurrence is not familiar to most emergency physicians. Early recognition and appropriate management of NMS may prevent significant morbidity and mortality.
D001480:Basal Ganglia Diseases / Q000175:diagnosis*; D002908:Chronic Disease; D003937:Diagnosis, Differential; D003989:Dibenzoxazepines / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004630:Emergencies; D005260:Female; D006801:Humans; D008152:Loxapine / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D012559:Schizophrenia / Q000188:drug therapy*; D014282:Trihexyphenidyl / Q000009:adverse effects / Q000627:therapeutic use
D003989:Dibenzoxazepines; D014282:Trihexyphenidyl; D008152:Loxapine